Bright Minds Biosciences (DRUG) EPS (Basic) (2023 - 2024)

Bright Minds Biosciences (DRUG) posted EPS (Basic) of $0.01 for Q4 2024, down 84.7% on a QoQ basis from $0.04 in Q2 2024, and up 101.79% year-over-year from $0.0 in Q1 2024.

Bright Minds Biosciences (DRUG) EPS (Basic) (2023 - 2024) Analysis & Trends

Bright Minds Biosciences' EPS (Basic) history runs 2 years deep, the most recent figure standing at $0.01 for Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.16
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.99
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.90
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Bright Minds Biosciences 681.98 Mn 681.98 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 0.01
Jun 30, 2024 0.04
Dec 31, 2023 -0.32
Jun 30, 2023 -0.29